Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35,547 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Corrigendum to "IL-32 aggravates metabolic disturbance in human nucleus pulposus cells by activating FAT4-mediated Hippo/YAP signaling" [Int. Immunopharmacol. 141 (2024) 112966].
Li P, Que Y, Wong C, Lin Y, Qiu J, Gao B, Zhou H, Hu W, Shi H, Peng Y, Huang D, Gao W, Qiu X, Liang A. Li P, et al. Among authors: zhou h. Int Immunopharmacol. 2024 Dec 25:113907. doi: 10.1016/j.intimp.2024.113907. Online ahead of print. Int Immunopharmacol. 2024. PMID: 39725593 No abstract available.
Low-added sugar dietary intervention study to mitigate glucose intolerance and improve body composition in adults with cystic fibrosis: a protocol of a double-blind, randomised study.
Zaveri S, Stecenko A, Hunt WR, Goss A, Sharma P, Hartman TJ, Easley K, Chandler JD, Burley TM, Driggers C, Ciccarella A, Zhou H, Narlow K, Ziegler TR, Daley T, Vellanki P, Alvarez J. Zaveri S, et al. Among authors: zhou h. BMJ Open. 2024 Dec 26;14(12):e092503. doi: 10.1136/bmjopen-2024-092503. BMJ Open. 2024. PMID: 39725418 Free article. Clinical Trial.
35,547 results
You have reached the last available page of results. Please see the User Guide for more information.